These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9044031)

  • 21. Bactericidal effect of combinations of cephalosporins with tobramycin on clinical isolates of Escherichia coli, Klebsiella and Staphylococcus aureus.
    Wagenvoort JH; Brus-Weijer L; Michel MF
    Arzneimittelforschung; 1986 Sep; 36(9):1301-2. PubMed ID: 3539124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interference by subinhibitory concentrations of azithromycin with the mechanism of bacterial adhesion to human epithelial cells.
    Braga PC; Piatti G
    Chemotherapy; 1993; 39(6):432-7. PubMed ID: 8222872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of the bacteriolytic and biochemical properties of ceftiolene (42980RP).
    Williamson R; Gutmann L; Kitzis MD; Acar JF
    J Antimicrob Chemother; 1984 Dec; 14(6):581-93. PubMed ID: 6394571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ceftriaxone on Pseudomonas aeruginosa and Staphylococcus aureus in broth, serum, and in combination with human polymorphonuclear leukocytes.
    Bassler M; Blaschke H; Just M; Daschner FD
    Chemotherapy; 1982; 28(5):390-6. PubMed ID: 6291868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibacterial activity and penicillin-binding protein affinity of new cephalosporin derivatives in Staphylococcus aureus and Escherichia coli.
    Singh MP; Lee YI; Singh R; Micetich RG; Wilkinson BJ
    J Antimicrob Chemother; 1991 Apr; 27(4):459-68. PubMed ID: 1856125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonistic effect of chloramphenicol in combination with cefotaxime or ceftriaxone.
    Asmar BI; Prainito M; Dajani AS
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1375-8. PubMed ID: 3195999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decrease in surface charge density of Klebsiella pneumoniae treated with cefodizime and enhancement of the phagocytic function of human polymorphonuclear leucocytes stimulated by the drug-treated bacteria.
    Muratsugu M; Miyake Y; Ishida N; Hyodo A; Terayama K
    Biol Pharm Bull; 1995 Sep; 18(9):1259-63. PubMed ID: 8845818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of sub-minimum inhibitory concentrations of cefodizime on the phagocytosis, intracellular killing and oxidative bursts of human polymorphonuclear leukocytes.
    Braga PC; Dal Sasso M; Mancini L; Sala MT
    Chemotherapy; 1999; 45(3):166-74. PubMed ID: 10224338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antibacterial activity of cefotaxime and desacetylcefotaxime, alone or in combination, against gram-positive cocci.
    Cruciani M; Navarra A; Di Perri G; Danzi MC; Concia E; Bassetti D
    Drugs Exp Clin Res; 1990; 16(11):565-8. PubMed ID: 2101779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bactericidal activity of cefodizime on Enterobacteriaceae in an in-vitro model simulating plasma pharmacokinetics in humans.
    Péchinot A; Neuwirth C; Bryskier A; Duez JM; Kazmierczak A
    J Antimicrob Chemother; 1997 Feb; 39(2):157-62. PubMed ID: 9069535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
    Nomura S; Nagayama A
    Chemotherapy; 1995; 41(4):267-75. PubMed ID: 7555207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of subinhibitory concentrations of cefotaxime, imipenem and ciprofloxacin on adhesion of Escherichia coli strains to polystyrene.
    Zalas-Wiecek P; Gospodarek E; Piecyk K
    Pol J Microbiol; 2011; 60(4):345-9. PubMed ID: 22390071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
    Concia E; Marone P; Verani D; Marino P
    Boll Ist Sieroter Milan; 1982; 61(4):300-8. PubMed ID: 6100233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphostructural damage and the inhibition of bacterial adhesiveness of Staphylococcus aureus and Moraxella catarrhalis induced by moxifloxacin.
    Braga PC; Culici M; Ricci D; Dal Sasso M
    J Chemother; 2003 Dec; 15(6):543-50. PubMed ID: 14998077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Activity of fourth generation cephalosporins against clinical isolates of Enterobacteriaceae].
    Tuchiluş C; Poiată A; Bădicuţ I; Teodor A; Luca V; Grigore L; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):595-8. PubMed ID: 14756068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro.
    Labro MT; el Benna J
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():49-57. PubMed ID: 2127416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotics and production of granulocyte-macrophage colony-stimulating factor by human bronchial epithelial cells in vitro. A comparison of cefodizime and ceftriaxone.
    Pacheco Y; Hosni R; Dagrosa EE; Gormand F; Guibert B; Chabannes B; Lagarde M; Perrin-Fayolle M
    Arzneimittelforschung; 1994 Apr; 44(4):559-63. PubMed ID: 8011012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.